American Society of Addiciton Medicine

Board of Directors


Board of Directors

Biography - Timothy Wiegand, MD, FACMT, FAACT, DFASAM

Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM specializes in Medical Toxicology and Addiction Medicine. He is an Associate Professor of Emergency Medicine and the Director of Toxicology and the Toxicology/Addiction Consult Service at Strong Memorial Hospital and the University of Rochester Medical Center. Dr. Wiegand is also the Medical Director for Huther Doyle, an addiction services provider in Rochester, New York, where he works in a collaborative model providing a variety of services for patients with substance use disorders, and serves as facilitator for their Project ECHO program on Pain, Opioid Prescribing and Addiction.

In addition to ED, hospital and clinic work treating drug exposures, intoxication, withdrawal and assisting with pain management for patients maintained on Medications for Opioid Use Disorder (MOUD) in the ED, hospital and perioperative setting, Dr. Wiegand is involved with medical education and research in toxicology and addiction. He is the Program Director for the UR Emergency Medicine & Toxicology based Addiction Medicine Fellowship and he is core faculty for the Emergency Medicine residency at Strong Memorial Hospital. He lectures locally, regionally, nationally and internationally on topics in addiction medicine and medical toxicology. Dr. Wiegand currently serves on the ASAM Board of Directors as Vice-President; and is completing a second term as board member of the American College of Medical Toxicology.

He is also is the President of the New York Chapter of the American Society of Addiction Medicine (NYSAM). Dr. Wiegand is particularly interested in the integration and collaboration between addiction medicine and medical toxicology. To this end he has Chaired and served on the Addiction Medicine Committee for ACMT and coordinated or participated in many presentations from toxicologists at the annual scientific meeting for ASAM as well as for his state chapter, NYSAM. He is also the Moderator for the new ACMT/ASAM Addiction and Toxicology Case Conference with emphasis on treatment of substance use disorder during the COVID19 pandemic which is broadcast live on the first Friday of each month from 1:00 to 2:00 EST and past webinars archived on the ASAM website.

Dr. Wiegand serves in volunteer capacity for many local, state and national committees including as Medical Director for overdose prevention programs in Rochester, New York, on state advisory panels for the Department of Health and New York Aids Institute, and for the New York Buprenorphine Work Group among others. He has been awarded the Charlotte Hegedus Award from the National Council on Alcoholism and Drug Dependence for professionals who have consistently demonstrated, for at least 5 years, a high level of cooperative work with individuals or groups with substance use disorders.

From ASAM Dr. Wiegand has been awarded the Millennium Labs Late Breaking Abstract Research Award Twice with submissions on A.) Addiction Medicine Training in Medical Toxicology Fellowship Programs and B.) The Interpretation of Buprenorphine Metabolite Levels in Urine Drug Testing. He was also the mentor and senior author to Dr. Jade Malcho whose poster: Three Cases of Buprenorphine Micro induction in Critically Ill Patients was awarded the 2020 Virtual ASAM Conference Young Investigator Award for Best Poster.

Disclosure of Interests and Affiliations